RBC Capital Markets has revised the price target for DCC plc, a leading international sales, marketing, and support services group, reducing it to 5,200 GBp from the previous 5,400 GBp.

Topps Tiles (LON: TPT) shares jumped at the start of Tuesday’s session after the company reported revenue and profit growth, and analysts highlighted “meaningful progress” on its strategic goals.

UK equities may be poised for renewed investor interest as global capital begins to reassess exposure to US markets, according to a research note from Franklin Templeton’s Martin Currie unit.

Greggs (LON: GRG) on Tuesday provided a positive update for the first 20 weeks of 2025, reaffirming its full-year outlook and sending shares higher in early London trading.

Cobalt Holdings PLC has announced its intention to float on the Main Market of the London Stock Exchange, aiming to raise approximately $230 million through its initial pub

InPost (AMS: INPST) has significantly expanded its footprint in the UK by installing 1,000 new parcel lockers, known as Paczkomaty, at Tesco stores. This brings the total number of InPost lockers in the UK to over 10,000. The

Rolls-Royce shares (LON: RR) have just come off another record setting week, with the new highs of 822.40p in Friday's session temporarily pushing the market cap to £70billion. Having re-tested support at 800p, the share pric

Diageo shares (LON: DGE) have come under pressure in recent years, down 47% since the start of 2022 as attitudes surrounding some of the firm's products shift. The world's

GSK has received approval for its Blenrep treatment for relapsed or refractory multiple myeloma from the Ministry of Health, Labour and Welfare in Japan. This approval follows positive results from two pivotal phase III trial

Kainos (LON: KNOS) shares declined on Monday after the IT services provider reported a 15% drop in adjusted pre-tax profit to £65.6 million for the year ended 31 March 2025. 

Premier Foods (LON: PFD) shares rose over 5% on Friday and have gained a further 0.4% in early Monday trading, extending their year-to-date gain to around 13.6%.  The

Natwest share price (LON: NWG) has ended the week with a new multi year high, with the mark of 506.60p coming as the bank closed the day up 1.3%. Now up 25.49% YTD, Natwest is trading at levels not seen since the financial cr

JPMorgan lowered its price target on Flutter Entertainment (LON: FLTR) from 27,000p to 26,800p but maintained an Overweight rating on the stock. Analyst Estelle Weingrod d

Bernstein cut its rating for Rentokil Initial (LON: RTO) from Market Perform to Underperform in a note to clients this week. The firm warned investors that the risk/reward

The FTSE 100 rallied into the close, fighting back from a bearish open that had seen the benchmark index shed more than 0.5% in the first 20 minutes of trading. From

National Grid shares (LON:NG.) are trading strongly today, up 3.69% after releasing an impressive set of full-year financial results for the fiscal year ending March 31,

Smith & Nephew shares (LON: SN) have been trading in a range for much of 2025, with the 1,000 level seemingly acting as a bit of a magnet for the stock. The company, a prominent FTSE 100 medical technology company, has se

Mondi (LON: MNDI) shares have gained attention this week after JPMorgan upgraded the stock from Neutral to Overweight, citing multiple catalysts for potential upside.  The

Watches of Switzerland Group (LON: WOSG) saw its shares rise more than 5% in early trading on Thursday after reporting full‑year revenue in line with market forecasts and strong second‑half momentum.

RBC Capital downgraded Associated British Foods (LON: ABF) from Outperform to Sector Perform in a note this week, maintaining a 2,150p price target on the stock. The bank p

3i Group's shares (LON: III) have had a strong start to 2025, with the YTD increase of 14.83% an impressive outperformance on the FTSE 100's gain of 4.15% over the sa

GSK's shares (LON: GSK) are up 1.1% in early London trading, moving back into positive territory on a YTD basis. The move comes as the company announced its agreement to acquire a phase III-ready liver disease drug, efimosfer

Analysts at Piper Sandler and HSBC continue to hold buy ratings on Shell (LON: SHEL) shares despite mixed adjustments to pric